Insights+

Top Performing Drugs of the Month - Keytruda

Top Performing Drugs of the Month - Keytruda

Active Ingredients: Pembrolizumab Strength: 100 mg/4 mL (25 mg/mL)...

Insights+: The US FDA New Drug Approvals in April 2022

Insights+: The US FDA New Drug Approvals in April 2022

The US FDA has approved 6 NDAs in Apr 2022, leading to treatments for patients and advances in the healthcare...

Insights+ Key Biosimilars Events of April 2022

Insights+ Key Biosimilars Events of April 2022

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...

Top Performing Drugs of the Month - Humira

Top Performing Drugs of the Month - Humira

Active Ingredients: Adalimumab Strength: 40 mg/0.8 ml D...

Top Performing Prescription Drugs of 2021: A Monthly Series by PharmaShots

Top Performing Prescription Drugs of 2021: A Monthly Series by PharmaShots

The year 2021 witnessed the global approval of vaccines and drugs amid COVID-19. The disease has been dominating the...

Insights+: The US FDA New Drug Approvals in March 2022

Insights+: The US FDA New Drug Approvals in March 2022

The US FDA has approved 9 NDAs and 1 BLAs in Mar 2022, leading to treatments for patients and advances in the...

Image